StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Outlook Therapeutics (OTLK) Climbs 41%
August 3, 2021 7:43 AM
Outlook Therapeutics (NASDAQ: OTLK) Climbs ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Next Articles
Outlook Therapeutics, Inc. (OTLK) Phase 3 Data Supports Approval - Analyst
August 3, 2021 11:54 AM
Outlook Therapeutics Incs. (OTLK) PT Raised to $6 at H.C. Wainwright
August 3, 2021 10:56 AM
Outlook Therapeutics (OTLK) Reports Positive Data from Pivotal Phase 3 NORSE TWO Trial of ONS-5010
August 3, 2021 6:03 AM
Outlook Therapeutics Reports Positive Efficacy and Safety Data from Pivotal Phase 3 NORSE TWO Trial of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
August 3, 2021 6:00 AM
